Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | NVS | LLY |
|---|---|---|
| Price | $143.38 | $1,187.15 |
| Change today | ▲ 0.47% | ▲ 3.14% |
| Market cap | $272.51B | $1.12T |
| Return, 3 months | -6.4% | +6.4% |
| Return, year to date | +7.1% | +11.0% |
| Return, 1 year | +20.1% | +61.0% |
| P/E (TTM) | 21.7 | 39.9 |
| P/B | 6.6 | 33.0 |
| P/E percentile vs own 5y | 70th | 5th |
| Dividend yield | 3.31% | 0.54% |
| Revenue growth (YoY, latest qtr) | +0.8% | +47.7% |
| Net profit growth (YoY) | -19.1% | +25.3% |
| Gross margin | 74.7% | 83.4% |
| Operating margin | 30.2% | 49.7% |
| Net margin | 22.5% | 33.5% |
| Return on equity | 30.5% | 102.4% |
| Analyst target vs. price | +24.0% | +15.6% |
| Analyst buy share | 67% | 86% |
| RSI (14) | 43 | 51 |
| 30-day volatility | 51.6% | 26.1% |
| Max drawdown, 1 year | -16.2% | -23.2% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.